P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors.
We describe herein the design, syntheses, and biological evaluation of new series of P4 tetrazole and adipic acid, ester, amide capped tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.